mRNA |
Epothilone B |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
LY-2157299 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
0.005 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
PF-562271 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.006 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.007 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.007 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.008 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.009 |